Lantheus Holdings, Inc. (LNTH) · Sep 21, 2026 · Acquisition

Lantheus resets FTC review clock for Curium merger without changing closing target

Antitrust review reset — New 30-day HSR waiting period expires October 21, 2026

Lantheus withdrew and refiled its antitrust notice, restarting the FTC waiting period. The deal timeline remains unchanged, but review is still active.

Lantheus is a radiopharmaceutical company centered on radiodiagnostics such as PYLARIFY, DEFINITY, Neuraceq and the newly approved TAUKLARIFY, while transitioning toward a Curium-owned structure. The filing changes the merger timetable mechanically, not economically. Curium withdrew its HSR filing on September 17 and resubmitted it on September 21, restarting a 30-day antitrust waiting period that expires October 21, 2026. 〔0〕

This is a procedural delay signal, not a disclosed regulatory setback. The companies explicitly describe withdrawal and refiling as routine and retain their expectation of closing in the first half of 2027, subject to FTC clearance, the shareholder vote and other closing conditions. 〔1〕 The important distinction is that the FTC review remains active; the filing does not say whether regulators have identified substantive concerns or will request additional information. 〔2〕

Bottom line: This mostly confirms the previously announced Curium acquisition while adding a fresh antitrust-review checkpoint. It matters for timing and execution risk, but the filing provides no new evidence that the transaction’s commercial terms or expected first-half 2027 closing window have changed.

What to watch next

HSR waiting period expires October 21, 2026

Original filing on SEC EDGAR

More Lantheus Holdings, Inc. news

Lantheus resets FTC review clock for Curium merger without changing closing target | LNTH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.